VALACICLOVIR EVOLUGEN 500 mg, film-coated tablet 42 tablets
Active ingredients: Valacyclovir hydrochloride, Valacyclovir
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet42 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- VALACICLOVIR EVOLUGEN 500 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC-Aluminium de 42 comprimé(s)
- Marketing authorisation holder
- EVOLUPHARM
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 17 May 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63416752CIP73958577CIP133400939585772Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| VALACICLOVIRcomprimé | 500 mg · un comprimé | FT |
| CHLORHYDRATE DE VALACICLOVIRcomprimé | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.